Cargando…
The European Medicines Agency's approval of new medicines for type 2 diabetes
Since 2005, more than 40 new medicines for the treatment of type 2 diabetes have been introduced on the market. These consist of 15 new active substances establishing three new classes of non‐insulin products, and several new or modified insulin products and combinations. The approval of these produ...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667915/ https://www.ncbi.nlm.nih.gov/pubmed/29740935 http://dx.doi.org/10.1111/dom.13349 |